Literature DB >> 19131001

Impact of cardiac rhythm on mitral valve area calculated by the pressure half time method in patients with moderate or severe mitral stenosis.

Hyung-Kwan Kim1, Yong-Jin Kim, Sung-A Chang, Dae-Hee Kim, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park.   

Abstract

BACKGROUND: The pressure half-time (PHT) method has been widely used to estimate mitral valve area (MVA) in patients with mitral stenosis (MS), in the belief that this simple method provides reliable information on true MVA. However, its limitation has been repeatedly recognized under different circumstances. The aim of this study was to evaluate the effect of cardiac rhythm on PHT-derived MVA calculation in relation to net atrioventricular compliance (C(n)).
METHODS: Patients (n = 41) with rheumatic pure moderate or severe MS were consecutively recruited. Eighteen patients with sinus rhythm were allocated to group 1 and the remaining patients with chronic atrial fibrillation to group 2. MVA was obtained using the PHT method and by planimetry (considered the gold standard in this study). C(n) was calculated with a previously validated equation.
RESULTS: There were no differences between the 2 groups in terms of age, gender, left ventricular dimensions or ejection fraction, or transmitral pressure gradient. Left atrial volume index (134.6 +/- 106.7 vs 79.2 +/- 16.8 mL; P = .003) and C(n) (6.6 +/- 1.5 vs 4.7 +/- 1.2 mL/mm Hg; P < .001) were higher in group 2 than in group 1. Disagreement of MVA estimation by PHT compared with that by 2-dimensional planimetry was 8.0 +/- 19.2% for group 1 and -24.9 +/- 13.9% for group 2 (P = .002). In addition, the extent of disagreement of PHT-derived MVA compared with that by 2-dimensional planimetry was significantly correlated with C(n) (r(2) = 0.71, P < .001). MVA by the PHT method was estimated to be substantially higher in patients with C(n) values < 4 mL/mm Hg, most of whom were in sinus rhythm. Multivariate analysis confirmed the independent association of cardiac rhythm with discrepancy of PHT-derived MVA compared with that by planimetry.
CONCLUSION: Changes in cardiac rhythm with associated modifications of C(n) can alter the accuracy of the PHT method for estimating MVA. Given the limitation described here, 2-dimensional planimetry, not the PHT method, should be used as a primary echocardiographic tool for MVA calculation.

Entities:  

Mesh:

Year:  2009        PMID: 19131001     DOI: 10.1016/j.echo.2008.11.007

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

1.  Simplifying proximal isovelocity surface area as an assessment method of mitral valve area in patients with rheumatic mitral stenosis by fixing aliasing velocity and mitral valve angle.

Authors:  Alaa Mabrouk Salem Omar; Mohammed Ahmed Abdel-Rahman; Hidekazu Tanaka; Osama Rifaie
Journal:  J Saudi Heart Assoc       Date:  2012-12-04

2.  Impact of net atrioventricular compliance on clinical outcome in mitral stenosis.

Authors:  Maria Carmo P Nunes; Judy Hung; Marcia M Barbosa; William A Esteves; Vinicius T Carvalho; Lucas Lodi-Junqueira; Cirilo P Fonseca Neto; Timothy C Tan; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-04       Impact factor: 7.792

3.  Assessment of mitral bioprostheses using cardiovascular magnetic resonance.

Authors:  Florian von Knobelsdorff-Brenkenhoff; André Rudolph; Ralf Wassmuth; Jeanette Schulz-Menger
Journal:  J Cardiovasc Magn Reson       Date:  2010-06-23       Impact factor: 5.364

4.  The impact of cardiac rhythm on the mitral valve area and gradient in patients with mitral stenosis.

Authors:  Hasan Arı; Selma Arı; Alper Karakuş; Sencer Camcı; Kübra Doğanay; Ahmet Tütüncü; Mehmet Melek; Tahsin Bozat
Journal:  Anatol J Cardiol       Date:  2017-05-24       Impact factor: 1.596

5.  Radius of proximal isovelocity surface area in the assessment of rheumatic mitral stenosis: Connecting flow to anatomy and hemodynamics.

Authors:  Alaa Mabrouk Salem Omar; Mohamed Ahmed Abdel-Rahman; Hala Raslan; Osama Rifaie
Journal:  J Saudi Heart Assoc       Date:  2015-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.